2024 Annual Meeting | S9 - Autonomic Disorders
| 11:15 AM - 11:27 AM MDT | Speaker |
2024 Irwin Schatz Award for Autonomic Disorders: This award recognizes early career investigators who have advanced the field of autonomic disorders, or senior investigators who have made major contributions to the field.
Steven Vernino, MD, PhD, FAAN |
| 11:27 AM - 11:39 AM MDT | Abstract |
002 - Randomized Controlled Trial of Intravenous Immunoblobulin for Autoimmune Postural Tachycardia Syndrome (iSTAND)
Steven Vernino, MD, PhD, FAAN |
| 11:39 AM - 11:51 AM MDT | Abstract |
003 - Neurofilament Light Chain in CSF and Plasma in Multiple System Atrophy – A Prospective, Longitudinal Biomarker Study
Wolfgang Singer, MD, FAAN |
| 11:51 AM - 12:03 PM MDT | Abstract |
004 - Long-term Outcomes in Seropositive Autoimmune Autonomic Ganglionopathy
Sandra Reiter-Campeau, MD |
| 12:03 PM - 12:15 PM MDT | Abstract |
005 - Side-by-Side Comparison of Commonly Used Beat-to-Beat Blood Pressure Devices in the Autonomic Laboratory During the Valsalva Maneuver
David M. Sletten, MBA |
| Eduardo E. Benarroch, MD, FAAN | Dr. Benarroch has nothing to disclose. |
| Phillip A. Low, MD, FAAN | Dr. Low has nothing to disclose. |
| Paola Sandroni, MD, PhD, FAAN | Dr. Sandroni has nothing to disclose. |
| Steven Vernino, MD, PhD, FAAN | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. |
| Tonette Gehrking | Tonette Gehrking has nothing to disclose. |
| Wolfgang Singer, MD, FAAN | Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care. |
| Ann M. Schmeichel | Ann M. Schmeichel has nothing to disclose. |
| Jade Gehrking | Jade Gehrking has nothing to disclose. |
| Amber Salter, PhD | Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers. The institution of Dr. Salter has received research support from Multiple Sclerosis Society of Canada. |
| Michelle L. Mauermann, MD, FAAN | The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care. |
| Sarah E. Berini, MD | Dr. Berini has nothing to disclose. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Melissa M. Cortez, DO | The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |
| Jeremy K. Cutsforth-Gregory, MD, FAAN | Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care. |
| Glen A. Cook, Jr., MD, FAAN | Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma. |
| Elizabeth A. Coon, MD, FAAN | Dr. Coon has nothing to disclose. |
| Meredith A. Bryarly, MD | The institution of Dr. Bryarly has received research support from Theravance. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| David M. Sletten, MBA | Mr. Sletten has nothing to disclose. |
| Kamal Shouman, MD | Dr. Shouman has nothing to disclose. |
| Sandra Reiter-Campeau, MD | Dr. Reiter-Campeau has nothing to disclose. |
| Timothy Lesnick | No disclosure on file |
| Mariana Suarez | No disclosure on file |
| Steve Hopkins | No disclosure on file |
| Jennifer Anderson | No disclosure on file |
| Roberto Hernandez | Roberto Hernandez has nothing to disclose. |
| Sarah McNamara | No disclosure on file |
| Damaris Conley | No disclosure on file |
| Pamela Bass | No disclosure on file |
| Jorge Trejo-Lopez | Jorge Trejo-Lopez has nothing to disclose. |